Endothelin Receptor Antagonists in Heart Failure
Authors:
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 64 (10) , 1029-1040
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Tezosentan in patients with acuteheart failure and acute coronary syndromesJACC, 2003
- RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edemaJACC, 2003
- A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathyEuropean Heart Journal, 2001
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?European Heart Journal, 2001
- Endothelin-1 Stimulates Cardiac Fibroblast Proliferation Through Activation of Protein Kinase CJournal of Molecular and Cellular Cardiology, 2000
- Stimulation of the Renin-Angiotensin System by Endothelin Subtype A Receptor Blockade in Conscious DogsHypertension, 1999
- Endothelin-Dependent Tone Limits Acetylcholine-Induced Dilation of Resistance Coronary Vessels After Blockade of NO Formation in Conscious DogsHypertension, 1998
- Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinoprilCardiovascular Research, 1996
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985